Senzar Asset Management, LLC 13F Holdings · last filed Q2 2018
Senzar Asset Management, LLC reported 24 securities worth $34.66M in its SEC 13F filing for Q2 2018 (period ended 2018-06-30). Top holdings: MRK (18.82%), SNY (8.87%), VTRS (8.70%). Among its top 25 positions this quarter: 6 new, 18 trimmed, 1 exited.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | MRK | MERCK & CO INC | $6.5M | 18.82% | 107,434 | Trimmed |
| 2 | SNY | SANOFI | $3.1M | 8.87% | 76,836 | Trimmed |
| 3 | VTRS | MYLAN N V | $3.0M | 8.70% | 85,495 | Trimmed |
| 4 | CI | CIGNA CORPORATION | $3.0M | 8.53% | 17,392 | Trimmed |
| 5 | AZN | ASTRAZENECA PLC | $2.5M | 7.23% | 71,400 | Trimmed |
| 6 | REGN | REGENERON PHARMACEUTICALS | $1.8M | 5.20% | 5,220 | Trimmed |
| 7 | RDUS1 | RADIUS HEALTH INC | $1.8M | 5.15% | 60,521 | New |
| 8 | GILD | GILEAD SCIENCES INC | $1.6M | 4.56% | 22,300 | New |
| 9 | CVS | CVS HEALTH CORP | $1.6M | 4.52% | 24,330 | Trimmed |
| 10 | AGN | ALLERGAN PLC | $1.5M | 4.20% | 8,723 | Trimmed |
| 11 | ALDR | ALDER BIOPHARMACEUTICALS INC | $1.4M | 3.90% | 85,558 | Trimmed |
| 12 | ANAB | ANAPTYSBIO INC | $1.1M | 3.27% | 15,970 | Trimmed |
| 13 | MCK | MCKESSON CORP | $1.0M | 2.89% | 7,500 | New |
| 14 | TBPH | THERAVANCE BIOPHARMA INC | $621,000 | 1.79% | 27,397 | Trimmed |
| 15 | MDXG | MIMEDX GROUP INC | $543,000 | 1.57% | 85,050 | Trimmed |
| 16 | ALNY | ALNYLAM PHARMACEUTICALS INC | $534,000 | 1.54% | 5,425 | New |
| 17 | ELGXQ | ENDOLOGIX INC | $517,000 | 1.49% | 91,422 | Trimmed |
| 18 | CNCE | CONCERT PHARMACEUTICALS INC | $502,000 | 1.45% | 29,821 | Trimmed |
| 19 | ARNA | ARENA PHARMACEUTICALS INC | $485,000 | 1.40% | 11,123 | Trimmed |
| 20 | TGTX | TG THERAPEUTICS INC | $415,000 | 1.20% | 31,594 | Trimmed |
| 21 | PTGX | PROTAGONIST THERAPEUTICS INC | $412,000 | 1.19% | 61,304 | Trimmed |
| 22 | FOMX | FOAMIX PHARMACEUTICALS LTD | $338,000 | 0.98% | 67,429 | New |
| 23 | UTHR | UNITED THERAPEUTICS CORP DEL | $297,000 | 0.86% | 2,625 | Trimmed |
| 24 | PRTA | PROTHENA CORP PLC | $249,000 | 0.72% | 17,090 | New |
| 25 | AERI | AERIE PHARMACEUTICALS INC | $0 | 0.00% | 0 | Exited |
Source: SEC Form 13F filings · as of 2018-06-30
Every position in this 13F-HR, with its change from the prior quarter.
13F holdings, latest quarter
SourceSEC EDGAR13F-HR